2024 Q2 Form 10-Q Financial Statement

#000199937124005847 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $114.0K $95.00K $537.0K
YoY Change -75.0% -82.31% 16.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $114.0K $95.00K $537.0K
YoY Change -75.0% -82.31% 16.74%
Operating Profit -$114.0K -$95.00K -$537.0K
YoY Change -75.0% -82.31% 16.74%
Interest Expense $1.585M $1.586M $1.866M
YoY Change -42.94% -15.01% 49.04%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $1.471M $1.491M $1.329M
YoY Change -36.65% 12.19% 67.8%
Income Tax $309.0K $313.0K $279.0K
% Of Pretax Income 21.01% 20.99% 20.99%
Net Earnings $1.162M $1.178M $1.050M
YoY Change -36.64% 12.19% 67.73%
Net Earnings / Revenue
Basic Earnings Per Share $0.28 $0.29 $0.25
Diluted Earnings Per Share $0.28 $0.29 $0.25
COMMON SHARES
Basic Shares Outstanding 4.078M shares 4.111M shares 4.168M shares
Diluted Shares Outstanding 4.107M shares 4.107M shares 4.168M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.00K $36.00K $6.000K
YoY Change 700.0% 500.0% 20.0%
Cash & Equivalents $16.00K $36.00K $6.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $108.3M $107.3M $101.6M
Other Receivables $108.3M $107.3M $101.6M
Total Short-Term Assets $108.7M $107.5M $101.9M
YoY Change 4.78% 5.5% 4.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.17M $11.17M $11.17M
YoY Change 0.0% 0.0% -2.87%
TOTAL ASSETS
Total Short-Term Assets $108.7M $107.5M $101.9M
Total Long-Term Assets $11.17M $11.17M $11.17M
Total Assets $119.8M $118.7M $113.1M
YoY Change 4.32% 4.95% 4.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $3.000K $35.00K
YoY Change -100.0% -91.43% 600.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.000K $35.00K
YoY Change -91.43% 600.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.000K $35.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $3.000K $35.00K
YoY Change -100.0% -91.43% 600.0%
SHAREHOLDERS EQUITY
Retained Earnings $59.37M $58.21M $51.08M
YoY Change 12.2% 13.96%
Common Stock $62.00M $62.00M $62.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.534M $1.534M $39.00K
YoY Change 3833.33% 3833.33%
Treasury Stock Shares
Shareholders Equity $119.8M $118.7M $113.0M
YoY Change
Total Liabilities & Shareholders Equity $119.8M $118.7M $113.1M
YoY Change 4.32% 4.95% 4.03%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $1.162M $1.178M $1.050M
YoY Change -36.64% 12.19% 67.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00K $552.0K
YoY Change 400.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$587.0K
YoY Change
NET CHANGE
Cash From Operating Activities -20.00K $552.0K
Cash From Investing Activities
Cash From Financing Activities 0.000 -$587.0K
Net Change In Cash -20.00K -$35.00K
YoY Change 400.0%
FREE CASH FLOW
Cash From Operating Activities -$20.00K $552.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
95569 shares
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58206000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57028000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
118669000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118078000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118672000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118078000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
218000 usd
CY2024Q1 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
29000 usd
CY2023Q1 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
319000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
95000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
537000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-95000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-537000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1586000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1866000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
313000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1178000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4107131 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4107131 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
118078000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1178000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
587000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
118669000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
113035000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1178000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2024Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-102000 usd
CY2023Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-345000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
731000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1426000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
552000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
587000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-587000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2024Q1 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1650000 shares
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
32608 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
587000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
524931 shares

Files In Submission

Name View Source Status
0001999371-24-005847-index-headers.html Edgar Link pending
0001999371-24-005847-index.html Edgar Link pending
0001999371-24-005847.txt Edgar Link pending
0001999371-24-005847-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ior-10q_033124.htm Edgar Link pending
ior-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ior-20240331_cal.xml Edgar Link unprocessable
ior-20240331_def.xml Edgar Link unprocessable
ior-20240331_lab.xml Edgar Link unprocessable
ior-20240331_pre.xml Edgar Link unprocessable
ior-10q_033124_htm.xml Edgar Link completed